In Practise Logo
In Practise Logo - Blue

Explore our full content library.

Lonza vs WuXi Biologics: BIOSECURE Act & U.S. Manufacturing Strategy

Partner Interview
Lonza Group•CH•Large CapCharles River Laboratories InternationalWuXi BiologicsCatalentThermo Fisher ScientificDanaherSwitching CostsMission Critical Products & Services
Feb 12, 2026

Medpace Holdings: Key Considerations in Selecting a CRO

Partner Interview
Medpace•US•Large CapIQVIAICONThermo Fisher ScientificSyneos HealthParexel InternationalFortreaCharles River Laboratories InternationalLonza GroupSwitching CostsMission Critical Products & Services
Nov 26, 2025

AGC Biologics & Western vs Chinese CDMOs

Partner Interview
AGC BiologicsWuXi BiologicsBayerLonza GroupThermo Fisher ScientificSartorius Stedim BiotechMerckPfizerCatalentSwitching CostsMission Critical Products & Services
Sep 19, 2025

Sartorius: Upstream Bioprocessing Market Dominance

Partner Interview
Sartorius Stedim Biotech•FR•Large CapDanaherGE AerospacePall CorporationMerckThermo Fisher Scientific3MRepligenLonza GroupRocheSwitching CostsMission Critical Products & Services
Aug 18, 2025

Aldevron: mRNA, Plasmids and Synthetic DNA

IP Icon
IP Interview
Danaher•US•Large CapCatalentThermo Fisher ScientificModernaGenscript Biotech CorporationLonza GroupSwitching CostsMission Critical Products & Services
Jul 30, 2025

Sartorius: Building Customer Lock-In Across the Biotech Lifecycle

Partner Interview
Sartorius Stedim BiotechDanaherThermo Fisher ScientificLonza GroupNovartisSanofiBioNTechSwitching CostsMission Critical Products & Services
Jun 26, 2025

Lonza, WuXi Biologics & CDMO Global Market: Competitive Landscape Evolution

Partner Interview
Lonza Group•CH•Large CapPfizerEli Lilly andNovo NordiskRocheWuXi BiologicsAGC Biologics
Feb 13, 2025

Lonza: CDMO Market Capacity

Partner Interview
Lonza Group•CH•Large CapCatalentSartorius Stedim BiotechAbbVieAvid BioservicesDanaherThermo Fisher ScientificCharles River Laboratories InternationalSwitching CostsMission Critical Products & Services
Jan 20, 2025

Danaher vs Thermo Fisher: Plasmid Manufacturing & Gene Therapy Positioning

IP Icon
IP Interview
Danaher•US•Large CapThermo Fisher ScientificLonza GroupCatalentCharles River Laboratories InternationalTwist BioscienceSwitching CostsMission Critical Products & Services
Jan 14, 2025

Danaher: Aldevron & DNA Plasmid Manufacturing

IP Icon
IP Interview
Danaher•US•Large CapSartoriusThermo Fisher ScientificCatalentLonza GroupSwitching CostsOEMs w/ Installed Base
Dec 16, 2024

Lifecore Biomedical: Customer Mix, Switching Cost & Power in the CDMO Value Chain

Partner Interview
Landec•US•Small CapNovo NordiskLonza GroupCatalent
Oct 6, 2024
Logo
IP Research Analysis

Danaher Cytiva: History, Moat, and Bundling Pall Filters

In Practise Research
IP ResearchDanaher•US•Large CapThermo Fisher ScientificMerckRepligenLonza GroupSartoriusSartorius Stedim BiotechBio-Rad LaboratoriesSwitching CostsOEMs w/ Installed Base
Oct 2, 2024

MaxCyte: Electroporation Technology, Cell & Gene Therapy & Competition

Partner Interview
MaxCyte•US•Small CapLonza GroupBio-Rad Laboratories
Sep 25, 2023

You've reached the end